Skip to main content

Heart Attack clinical trials at UCSF

3 in progress, 1 open to eligible people

Showing trials for
  • Transfusion Trigger After Operations in High Cardiac Risk Patients

    open to eligible people ages 18 years and up

    The goal of the proposed study is to determine whether a liberal transfusion strategy (transfusion trigger at Hb < 10 gm/dl) in Veterans at high cardiac risk who undergo major open vascular and general surgery operations is associated with decreased risk of adverse postoperative outcomes compared to a restrictive transfusion strategy (transfusion trigger at Hb < 7 gm/dl).

    San Francisco, California and other locations

  • Addressing Social Vulnerabilities in Cardiovascular Disease

    Sorry, not yet accepting patients

    The investigators will conduct a feasibility study of an enhanced transitional care intervention, that will: 1) automate identification and risk-stratification of patients with CHF and IHD with social vulnerabilities; 2) incorporate a new standardized social vulnerabilities screening tool into clinical care; 3) enable electronic referrals to community resources; and 4) add novel community-based interventions to the existing medically-oriented transitional care intervention that is the standard of care at the study hospital (Parkland Hospital in Dallas, Texas) and other hospitals nationwide.

  • An Observational Study of Beta-Blocker Use in Patients With COPD and Acute MI

    Sorry, not currently recruiting here

    The study is a prospective, observational study of patients admitted to the BLOCK COPD network hospitals with acute AMI and COPD to determine the prevalence of COPD in patients admitted to the hospital with an acute myocardial infarction (AMI) and to characterize the phenotypic expression and severity of their underlying lung disease. Patients with will be identified via the EMR. 571 participants will be enrolled.

    Fresno, California and other locations

Our lead scientists for Heart Attack research studies include .

Last updated: